Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Accounts Payables (2020 - 2025)

Historic Accounts Payables for BioScience Health Innovations (BHIC) over the last 6 years, with Q3 2025 value amounting to $10165.0.

  • BioScience Health Innovations' Accounts Payables rose 2033.86% to $10165.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $10165.0, marking a year-over-year increase of 2033.86%. This contributed to the annual value of $8226.0 for FY2024, which is 717.92% up from last year.
  • According to the latest figures from Q3 2025, BioScience Health Innovations' Accounts Payables is $10165.0, which was up 2033.86% from $16636.0 recorded in Q2 2025.
  • BioScience Health Innovations' 5-year Accounts Payables high stood at $16636.0 for Q2 2025, and its period low was $760.0 during Q1 2021.
  • Over the past 5 years, BioScience Health Innovations' median Accounts Payables value was $6683.0 (recorded in 2022), while the average stood at $6865.6.
  • As far as peak fluctuations go, BioScience Health Innovations' Accounts Payables soared by 73618.42% in 2022, and later crashed by 7221.53% in 2024.
  • Over the past 5 years, BioScience Health Innovations' Accounts Payables (Quarter) stood at $3284.0 in 2021, then fell by 12.7% to $2867.0 in 2022, then surged by 167.7% to $7675.0 in 2023, then grew by 7.18% to $8226.0 in 2024, then rose by 23.57% to $10165.0 in 2025.
  • Its Accounts Payables stands at $10165.0 for Q3 2025, versus $16636.0 for Q2 2025 and $16415.0 for Q1 2025.